Company Filing History:
Years Active: 2019-2022
Title: Innovations by John W. Luecke in Medical Diagnostics
Introduction
John W. Luecke is a notable inventor based in Tucson, AZ (US), recognized for his contributions to medical diagnostics. He holds a total of 3 patents that focus on innovative methods for diagnosing and classifying diseases, particularly in the field of oncology.
Latest Patents
One of his latest patents is titled "Methods for subtyping diffuse large B-cell lymphoma (DLBCL)." This innovation describes techniques for classifying subtypes of DLBCL, which can significantly aid in diagnosis, prognosis, and therapy selection. The classifier developed can effectively categorize subtypes of DLBCL, providing valuable insights for medical practices and improving outcomes for DLBCL patients. Additionally, the patent includes arrays and kits designed to measure the expression of DLBCL signature genes.
Another significant patent by Luecke is "Methods of detecting gene fusions." This patent discloses methods for detecting the presence of a gene fusion in a sample from a subject. The methods utilize a fusion probe that spans the point of fusion between two nucleic acids or genes. In some embodiments, the methods employ two or more probes that flank the fusion point, allowing for precise detection. Furthermore, the methods can determine the percentage of gene fusion in the sample relative to the first or second nucleic acid.
Career Highlights
John W. Luecke is currently associated with Htg Molecular Diagnostics, Inc., where he continues to advance his research and innovations in the field of molecular diagnostics. His work has been instrumental in developing tools that enhance the accuracy of cancer diagnostics.
Collaborations
Luecke collaborates with notable colleagues such as Bruce Seligmann and Bj Kerns, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
John W. Luecke's contributions to medical diagnostics through his patents reflect his commitment to improving patient care and advancing scientific knowledge. His work continues to influence the field of oncology and diagnostic methods.